Barclays Maintains Overweight on UnitedHealth Group, Lowers Price Target to $440

Benzinga · 3d ago
Barclays analyst Andrew Mok maintains UnitedHealth Group (NYSE:UNH) with a Overweight and lowers the price target from $441 to $440.